Sarepta Therapeutics (SRPT) Receivables Refunds (2023 - 2025)
Historic Receivables Refunds for Sarepta Therapeutics (SRPT) over the last 3 years, with Q3 2025 value amounting to $14.3 million.
- Sarepta Therapeutics' Receivables Refunds rose 2519.7% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year increase of 2519.7%. This contributed to the annual value of $13.1 million for FY2024, which is 9137.28% up from last year.
- Per Sarepta Therapeutics' latest filing, its Receivables Refunds stood at $14.3 million for Q3 2025, which was up 2519.7% from $7.2 million recorded in Q2 2025.
- Sarepta Therapeutics' 5-year Receivables Refunds high stood at $14.3 million for Q3 2025, and its period low was $6.9 million during Q4 2023.
- Moreover, its 3-year median value for Receivables Refunds was $8.4 million (2024), whereas its average is $9.8 million.
- Per our database at Business Quant, Sarepta Therapeutics' Receivables Refunds skyrocketed by 9137.28% in 2024 and then plummeted by 1391.56% in 2025.
- Sarepta Therapeutics' Receivables Refunds (Quarter) stood at $6.9 million in 2023, then surged by 91.37% to $13.1 million in 2024, then increased by 8.89% to $14.3 million in 2025.
- Its Receivables Refunds was $14.3 million in Q3 2025, compared to $7.2 million in Q2 2025 and $7.0 million in Q1 2025.